Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03885531 · ClinicalTrials.gov registry record
Safety and Performance of JOURNEY™ II Cruciate Retaining (CR) Total Knee System (TKS)
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 586
- Enrollment target
NCT03885531 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 586 participants.
The verdict
NCT03885531 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 586 participants
- Enrollment target
Study Summary
The objective of this study is to examine the safety and performance of the Journey II CR TKS based on retrospective data.
Interventions
- DEVICE Total knee arthroplasty with Journey II CR Total Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 586 participants |
| Start Date | 2019-03-27 |
| Est. Completion | 2020-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03885531
The ClinicalTrials.gov registry entry for NCT03885531 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 586 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Total knee arthroplasty with Journey II CR Total Knee System is the first listed.
NCT03885531 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03885531 about?
NCT03885531 is a clinical study titled "Safety and Performance of JOURNEY™ II Cruciate Retaining (CR) Total Knee System (TKS)". The objective of this study is to examine the safety and performance of the Journey II CR TKS based on retrospective data.
What is the current status of trial NCT03885531?
This trial is currently completed. The enrollment target is 586 participants. The study started on 2019-03-27. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03885531?
The interventions under investigation include: Total knee arthroplasty with Journey II CR Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT03885531?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.